Cannabis & Glaucoma
$49.00
This curriculum was developed in 2021 and reflects the scientific and clinical understanding available at that time. As this field continues to advance, we are preparing a comprehensive curriculum update incorporating the latest research and best practices. The new program is expected to launch in Q4 2026. Subscribe to receive updates and early access information.
Jeff Hergenrather, MD presents on glaucoma and how cannabinoids may be a beneficial treatment option. This course explores eye physiology and the clinical effects of cannabis/cannabinoids on the human eye. This includes how cannabis may be used to reduce eye pressure, eye damage, and loss of vision associated with this disease. Dr. Hergenrather outlines the considerations of cannabis as an adjunct to conventional therapy for glaucoma and reports on landmark cases that brought this topic to the forefront.
*Includes a certificate of completion
